Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.
about
Identification of novel tumor-associated cell surface sialoglycoproteins in human glioblastoma tumors using quantitative proteomicsPreclinical toxicity evaluation of a novel immunotoxin, D2C7-(scdsFv)-PE38KDEL, administered via intracerebral convection-enhanced delivery in rats.EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced delivery.Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.Generation and characterization of a IgG monoclonal antibody specific for GM3 (NeuGc) ganglioside by immunizing β3Gn-T5 knockout mice.Trends in Malignant Glioma Monoclonal Antibody Therapy.
P2860
Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Affinity-matured recombinant i ...... '-isoLD1 on malignant gliomas.
@en
Affinity-matured recombinant i ...... '-isoLD1 on malignant gliomas.
@nl
type
label
Affinity-matured recombinant i ...... '-isoLD1 on malignant gliomas.
@en
Affinity-matured recombinant i ...... '-isoLD1 on malignant gliomas.
@nl
prefLabel
Affinity-matured recombinant i ...... '-isoLD1 on malignant gliomas.
@en
Affinity-matured recombinant i ...... '-isoLD1 on malignant gliomas.
@nl
P2093
P2860
P356
P1476
Affinity-matured recombinant i ...... '-isoLD1 on malignant gliomas.
@en
P2093
Charles N Pegram
Chien-Tsun Kuan
Hailan Piao
Ira H Pastan
Jan-Eric Månsson
Stephen T Keir
Vidya Chandramohan
P2860
P304
P356
10.4161/MABS.25860
P577
2013-07-25T00:00:00Z